This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders APAC
September 1-2, 2026
Marina Bay Sands, Sands Expo & Convention CentreSingapore

Zee-Fen Chang
Chair Professor, Institute of Molecular Medicine, Director, Center of Nucleic Acid Medicines at College of Medicine, National Taiwan University
Speaker

Profile

The high frequency of RNA virus mutations and the outbreak of emergent RNA viral infection remain the challenging issues in public health. We observe the synthesis of VSV RNAs at mitochondria/endoplasmic reticulum (Mito/ER) spheres, accompanied by the leakage of endonuclease G (ENDOG), a mitochondrial nuclease, to the cytosol. We provide evidence that ENDOG released from mitochondria is a host anti-viral factor by eliminating viral RNAs for replication. However, ENDOG outside mitochondria can translocate to nuclei and cause nuclear DNA damages. We engineer an ENDOG expressed on mitochondrial outer membrane (MOM), namely MOM-ENDOG, to increase the accessibility to viral RNA transcripts synthesized at mitochondrial sites without damaging nuclear DNA (nDNA). Delivery of modified mRNA of wild-type but not catalytic-dead MOM-ENDOG markedly suppresses the propagation of VSV, Influenza, Dengue and Zika virus. Thus, the mRNA encoding organelle-specific viral RNA degrader can be developed to a broad-spectrum anti-viral agent.

Agenda Sessions

  • Presentation: RNA-based Therapeutics: One Agent Against Multiple Types of RNA Viruses

    5:00pm

At this event